COVID-19 rapid guideline : managing the long-term effects of COVID-19 (Record no. 3788)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01972nam a22002297a 4500 |
| 001 - CONTROL NUMBER | |
| control field | D0001C000163 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210326111328.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210326b ||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Description conventions | rda |
| 245 00 - TITLE STATEMENT | |
| Title | COVID-19 rapid guideline : managing the long-term effects of COVID-19 |
| Remainder of title | managing the long-term effects of COVID-19 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London : |
| Name of publisher, distributor, etc. | National Institute for Health and Care Excellence, |
| Date of publication, distribution, etc. | 2020. |
| 336 ## - CONTENT TYPE | |
| Source | rdacontent |
| Content type | text |
| 337 ## - MEDIA TYPE | |
| Source | rdamedia |
| Media type | unmediated |
| 338 ## - CARRIER TYPE | |
| Source | rdacarier |
| Carrier type term | volume |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID.<br/><br/>This guideline has been developed jointly by NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP).<br/><br/>To develop the recommendations, we have used the following clinical definitions for the initial illness and long COVID at different times:<br/><br/>Acute COVID-19: signs and symptoms of COVID-19 for up to 4 weeks.<br/><br/>Ongoing symptomatic COVID-19: signs and symptoms of COVID-19 from 4 to 12 weeks.<br/><br/>Post-COVID-19 syndrome: signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis.<br/><br/>When using this guideline, follow the usual professional guidelines, standards and laws (including those on equalities, safeguarding, communication and mental capacity), as described in making decisions using NICE guidelines. |
| 600 #2 - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Field link and sequence number | COVID-19 |
| 600 #2 - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Field link and sequence number | Long Term Adverse Effects |
| 600 #2 - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Field link and sequence number | Guideline |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://www.ncbi.nlm.nih.gov/books/NBK567261/">https://www.ncbi.nlm.nih.gov/books/NBK567261/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | National Library of Medicine |
| Koha item type | COVID 19 Resource |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National Library of Medicine | DOH Central Library | DOH Central Library | Electronic Resource Section | 03/26/2021 | COVID-19-000163 | D0001C000163 | 03/26/2021 | 03/26/2021 | COVID 19 Resource |